To determine whether thrombolysis and reperfusion were beneficial after 4.5 h , we examined clinical and radiological outcomes in patients treated with tissue plasminogen activator or placebo within 4.5-6h , using data from the Echoplanar Imaging Thrombolytic Evaluation Trial .